載入...
Successful Treatment of Chronic Hepatitis C with Triple Therapy in an Opioid Agonist Treatment Program
BACKGROUND: People who inject drugs (PWID) constitute 10 million people globally with hepatitis C virus, including many opioid agonist treatment patients. Little data exist describing clinical outcomes for patients receiving HCV treatment with direct-acting antiviral agents (DAAs) in opioid agonist...
Na minha lista:
| 發表在: | Int J Drug Policy |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4833390/ https://ncbi.nlm.nih.gov/pubmed/26341685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugpo.2015.08.008 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|